Concord Biotech Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Mar '24
    Total Qtr Revenue cr
    439.27
    258.95
    320.21
    226.11
    329.78
    Other Income Qtr Cr9.3814.7310.0310.3110.81
    Operating Revenues Qtr429.88244.22310.18215.80318.97

    *All values are in Cr.

    Operating Expenses Qtr
    239.46
    146.27
    173.50
    134.52
    184.68
    Operating Profit Qtr
    190.42
    97.95
    136.68
    81.28
    134.29
    EBITDA Qtr Cr
    199.81
    112.68
    146.70
    91.59
    145.10
    Depreciation Qtr
    14.62
    13.26
    13.31
    13.18
    13.72
    Net Profit Qtr
    140.39
    75.92
    95.74
    59.59
    95.02
    Basic EPS Qtr
    13.42
    7.26
    9.15
    5.70
    9.08
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -